|A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer|
RC Coombes, E Hall, LJ Gibson, R Paridaens, J Jassem, T Delozier, ...
New England Journal of Medicine 350 (11), 1081-1092, 2004
|Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial|
RE Mansel, L Fallowfield, M Kissin, A Goyal, RG Newcombe, JM Dixon, ...
Journal of the National Cancer Institute 98 (9), 599-609, 2006
|Communicating sad, bad, and difficult news in medicine|
L Fallowfield, V Jenkins
The Lancet 363 (9405), 312-319, 2004
|Information needs of patients with cancer: results from a large study in UK cancer centres|
V Jenkins, L Fallowfield, J Saul
British journal of cancer 84 (1), 48-51, 2001
|Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.|
LJ Fallowfield, A Hall, GP Maguire, M Baum
British medical journal 301 (6752), 575-580, 1990
|Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial|
RC Coombes, LS Kilburn, CF Snowdon, R Paridaens, RE Coleman, ...
The Lancet 369 (9561), 559-570, 2007
|Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial|
L Fallowfield, V Jenkins, V Farewell, J Saul, A Duffy, R Eves
The Lancet 359 (9307), 650-656, 2002
|Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK …|
U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ...
The lancet oncology 10 (4), 327-340, 2009
|Psychiatric morbidity and its recognition by doctors in patients with cancer|
L Fallowfield, D Ratcliffe, V Jenkins, J Saul
British journal of cancer 84 (8), 1011-1015, 2001
|Information needs of cancer patients in west Scotland: cross sectional survey of patients' views|
C Meredith, P Symonds, L Webster, D Lamont, E Pyper, CR Gillis, ...
Bmj 313 (7059), 724-726, 1996
|Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial|
IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...
The Lancet 387 (10022), 945-956, 2016
|Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction|
SK Al-Ghazal, L Fallowfield, RW Blamey
European journal of cancer 36 (15), 1938-1943, 2000
|ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)|
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
The Breast 23 (5), 489-502, 2014
|What is quality of life|
What is 2, 2009
|4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)|
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
|Multidisciplinary teams in cancer care: are they effective in the UK?|
A Fleissig, V Jenkins, S Catt, L Fallowfield
The lancet oncology 7 (11), 935-943, 2006
|Effective communication skills are the key to good cancer care|
L Fallowfield, V Jenkins
European Journal of Cancer 35 (11), 1592-1597, 1999
|Truth may hurt but deceit hurts more: communication in palliative care|
LJ Fallowfield, VA Jenkins, HA Beveridge
Palliative medicine 16 (4), 297-303, 2002
|3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)|
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
|Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of …|
A Fleissig, LJ Fallowfield, CI Langridge, L Johnson, RG Newcombe, ...
Breast cancer research and treatment 95 (3), 279-293, 2006